Early Prostate Cancers Can Harbor Aggressive Tumor Cells

Duke researchers have identified a genomic signature which makes it possible to develop a test to identify which men should undergo treatment early in their diagnosis, vs. those who could safely postpone therapy, if they need it at all.

A Lemur’s Rare Cancer Could Shed Light on Human Disease

When 10-month-old Winnie, a rare, long-fingered lemur at the Duke Lemur Center, was diagnosed with cancer this summer, specialists worldwide, including doctors from Duke, rallied around to give her the best care. The scientific insights gained from her short life could help animals and humans too.

Local Hospital Leaders Urge Public to Avoid Emergency Rooms for COVID Testing

Get vaccinated against COVID-19 or you dramatically increase your risk of ending up on a ventilator and further taxing local hospitals as local cases of the virus surge. That’s the message from chief medical officers from three Triangle health systems during a media briefing Thursday. Watch the briefing here.

Geoff Ginsburg Reflects on His Time as Director of MEDx

Geoff Ginsburg, MD, PhD, professor of medicine, pathology, and biostatistics and bioinformatics, and the founding director of MEDx (Medicine + Engineering at Duke), will step down as director in January 2022. In an interview, he reflects on the creation of MEDx and its accomplishments, people, growth, and more.